Your browser does not support JavaScript!
COVID-19 : Découvrez les Plans de Continuité d’Activité des entreprises de l’environnement
Logo de FierceBiotech

FierceBiotech Source d'actualité

Une actualité de FierceBiotech a été ajouté(e)
Hier à 19:48
Aveo gives up on ficlatuzumab in acute myeloid leukemia, citing COVID-19
Back in 2012, Aveo announced that its second most advanced asset, ficlatuzumab, had flopped in a midstage cancer test; for years, we heard nothing about this drug....
www.fiercebiotech.com
Une actualité de FierceBiotech a été ajouté(e)
Hier à 15:43
ACC: Regeneron’s Praluent sidekick cuts cholesterol in half—even in hard-to-treat patients
Regeneron revealed last summer that its latest cholesterol fighter, evinacumab, cut “bad” cholesterol in half for patients with a rare genetic disorder. Now, in full results presented virtually at the...
www.fiercebiotech.com
Une actualité de FierceBiotech a été ajouté(e)
Hier à 14:05
COVID-19 causes Moderna to pause a clutch of clinical trials
Moderna has become the latest company to hit pause on clinical trials in response to the COVID-19 pandemic. The biotech, which is leading efforts to develop a COVID-19 vaccine, is pausing enrollment...
www.fiercebiotech.com
Une actualité de FierceBiotech a été ajouté(e)
Hier à 11:52
J&J, BARDA commit $1B to COVID-19 vaccine R&D
Johnson & Johnson has joined with a U.S. government agency to commit $1 billion to development of a COVID-19 vaccine. J&J plans to have a vaccine in the clinic by September, win emergency use...
www.fiercebiotech.com
Une actualité de FierceBiotech a été ajouté(e)
Hier à 07:36
Battelle deploys decontamination system for reusing N95 masks
Battelle received an emergency go-ahead from the FDA over the weekend to deploy its decontamination system for personal protective equipment, allowing healthcare workers to clean and reuse scarce N95...
www.fiercebiotech.com
Charger plus d'actualités

Informations juridiques
SIREN / SIRET USA Washington, DC

Adresse
Washington DC USA- Washington, DC Etats-Unis